Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Physiologically Relevant Cell Culture Handbook
Tuesday, April 01, 2014
48-page handbook is also a resource for neuroscience, drug discovery and regenerative medicine applications.

Traceable Tissue Storage Solution
Friday, March 28, 2014
Micronic’s new 3.00ml tissue tubes provide easy and unambiguous storage.

Device for Removal of Dying and Dead Cells
Saturday, March 22, 2014
ClioCell™ from AMSBIO provides new opportunities to optimize cell growth, culture and storage.

Cellular Dynamics Announces Presentations at the SOT Annual Meeting
Saturday, March 22, 2014
Highlighting use of iPSC-derived human cells for environmental toxicology and drug toxicity testing.

New PrimeSurface™ Culture Ware Now Available from Alpha Laboratories
Saturday, March 15, 2014
Ideal for spheroid cell colony formation.

GE Healthcare Launches New Cell Culture Solution Product; Xuri™ MSC Medium
Tuesday, March 11, 2014
The product and attachment enable serum-free and xeno-free expansion of human mesenchymal stem cells.

Lightweight Modular Chest Freezer Rack
Friday, February 28, 2014
Ideally constructed for long term storage at ultra-low temperatures.

Greiner Bio-One Presents Innovative Cryo.s Biobanking Tubes
Friday, February 14, 2014
An innovative solution for storing biological samples in biorepositories.

Intelsius Enhances Patient Safety Products
Thursday, February 13, 2014
Company announces enhancement to ThermoTrek™ range of solutions.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 482
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv